Department of Justice July 2017 – Federal Register Recent Federal Regulation Documents

The Department of Justice (DOJ), Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF), will submit the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection was previously published in the [Federal Register, on May 25, 2017, allowing for a 60-day comment period].

Registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as bulk manufacturers of various classes of controlled substances.

The Department of Justice (DOJ), Drug Enforcement Administration (DEA), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection was previously published in the Federal Register, on May 15, 2017, allowing for a 60 day comment period.

The Department of Justice (DOJ), Drug Enforcement Administration (DEA), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection was previously published in the Federal Register, on May 15, 2017, allowing for a 60 day comment period.

Department of Justice (DOJ), Federal Bureau of Investigation, Criminal Justice Information Services Division will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. This proposed information collection was previously published in the Federal Register May 16, 2017, allowing for a 60 day comment period.

Department of Justice (DOJ), Federal Bureau of Investigation (FBI), Training Division's Curriculum Management Section (CMS) will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. This proposed information collection was previously published in the Federal Register, on May 12, 2017, allowing for a 60 day comment period.

The Drug Enforcement Administration (DEA) is finalizing the designation of the chemical alpha-phenylacetoacetonitrile (APAAN) and its salts, optical isomers, and salts of optical isomers, as a list I chemical under the Controlled Substances Act (CSA). The DEA proposed control of APAAN, due to its use in clandestine laboratories to illicitly manufacture the schedule II controlled substances phenylacetone (also known as phenyl-2-propanone or P2P), methamphetamine, and amphetamine. This rulemaking finalizes, without change, the control of APAAN as a list I chemical. This action does not establish a threshold for domestic and international transactions of APAAN. As such, all transactions involving APAAN, regardless of size, shall be regulated. In addition, chemical mixtures containing APAAN are not exempt from regulatory requirements at any concentration. Therefore, all transactions of chemical mixtures containing any quantity of APAAN shall be regulated pursuant to the CSA. However, manufacturers may submit an application for exemption for those mixtures that do not qualify for automatic exemption.

The National Institute of Justice (NIJ) announces publication of Minimum Scheme Requirements to Certify Criminal Justice Restraints Described in NIJ Standard 1001.00. The minimum scheme requirements are found in the Supplementary Information below, as well as in the document found here: https://www.ncjrs.gov/pdffiles1/nij/250566.pdf. NIJ Standard 1001.00, Criminal Justice Restraints Standard, was published in the Federal Register on November 19, 2014, and may be found here: https://federalregister.gov/a/2014-27367. All references to ``Criminal Justice Restraints Certification Program Requirements, NIJ CR-1001.00'' in NIJ Standard 1001.00, including in Section 1.1.1 of that standard, shall be understood to refer to the Minimum Scheme Requirements published here. NIJ has been working with conformity assessment bodies to develop acceptable criteria by which NIJ would recognize a product certification scheme operated by a certification body in the private sector. Certification better ensures that quality restraints are available to criminal justice practitioners. In the interest of officer safety and public safety, NIJ anticipates recognizing certification programs in the private sector that meet or exceed the minimum scheme requirements. Certification bodies that are interested in developing a product certification scheme for restraints described in NIJ Standard 1001.00 should contact NIJ at the contact information listed below. As previously noted (https://www.federalregister.gov/d/2016-22057), Safety Equipment Institute (SEI), which is accredited by the American National Standards Institute (ANSI) to ISO/IEC 17065 Conformity assessment Requirements for bodies certifying products, processes and services, has established a certification program for restraints described in NIJ Standard 1001.00. ISO/IEC 17065 is a joint endeavor of the International Organization for Standardization (ISO) and the International Electrotechnical Commission (IEC). Further guidance on recognition of this certification program or others will be published in the Federal Register at a future date, to be determined.

The Department of Justice (DOJ), Office of Justice Programs, National Institute of Justice, will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.

The Drug Enforcement Administration (DEA) proposes to remove naldemedine (4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,7,9-trihydroxy- N-(2-(3-phenyl-1,2,4-oxadiazol-5-yl)propan-2-yl)-2,3,4,4a,5,7 a- hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-6-carbo xamide) including its salts from the schedules of the Controlled Substances Act (CSA). This action is pursuant to the CSA which requires that such actions be made on the record after opportunity for a hearing through formal rulemaking. Naldemedine is currently a schedule II controlled substance because it can be derived from opium alkaloids. This action would remove the regulatory controls and administrative, civil, and criminal sanctions applicable to controlled substances, including those specific to schedule II controlled substances, on persons who handle (manufacture, distribute, reverse distribute, dispense, conduct research, import, export, or conduct chemical analysis) or propose to handle naldemedine.

Department of Justice (DOJ), Office of Justice Programs, Bureau of Justice Statistics, will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. This proposed information collection was previously published on May 3, 2017 allowing for a 60 day comment period. Comments from the public were received during this period and are thoroughly addressed in the supporting statement for this collection.